Free Online CME/NCPD

New Clinical Perspectives in the Management of Myelofibrosis

1.0 CME | 1.0 MOC | ILNA Points

In this online activity, Srdan Verstovsek, MD, PhD, explores predictive and prognostic markers for personalized care planning in myelofibrosis as well as emerging data in therapeutic strategies and the implications that research advances may have for future practice.

Exploring Novel Treatment Strategies for Metastatic Colorectal Cancer

1.25 CME | 1.25 MOC

In this online activity, Jaffer Ajani, MD, MD Anderson Cancer Center, will review emerging data on novel therapies for patients with metastatic disease, including TKIs, monoclonal antibodies, immune checkpoint inhibitors, and cytotoxic therapy. Case challenges will be used to illustrate strategies for optimizing treatment in the context of confounding patient and tumor variables. Start the activity!

Clinical Updates and Expert Guidance in Prostate Cancer

1.25 CME | 1.25 MOC

In this online activity, Judd Moul, MD, Duke University School of Medicine, reviews emerging data on novel therapies for metastatic castration-sensitive, metastatic castration-resistant, and nonmetastatic castration-resistant disease. Case challenges are used to illustrate strategies for optimizing treatment in the context of confounding patient and tumor variables. Start now!

Novel Treatment Options in Mantle Cell Lymphoma With Gilles Salles, MD, PhD

0.25 CME | 0.25 MOC

Our third Oncology Data Advisor™ episode talks to Gilles Salles, MD, PhD, about efficacy of newly developed therapies, adverse events associated with these treatments, ongoing research, and advice for clinicians seeking to optimize outcomes for patients with MCL.

Virtual Tumor Board: Diagnosis and Management of Myelodysplastic Syndromes

1.0 CME | 1.0 NCPD | 1.0 MOC

In this virtual tumor board, David P. Steensma, MD, FACP, Reza Nejati, MD, and Ilene Galinsky, BSN, MSN, ANP-C, discuss patient and tumor characteristics that inform personalized care plans, risk stratification, and supportive care strategies for patients with MDS.

Optimizing Personalized Care Plans for Patients With Advanced Non-Small Cell Lung Cancer

1.5 CME | 1.5 NCPD | 1.5 MOC

Learn more about personalized care plans in advanced NSCLC with Mark A. Socinski, MD, Maureen F. Zakowski, MD and Victoria Sherry, DNP, CRNP, AOCNP^® as they discuss prognostic markers, current therapies, and adverse event management in this multidisciplinary virtual tumor board.

Multiple Myeloma: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

1.0 NCPD | ILNA Points

In this free NCPD activity, Beth Faiman, PhD, MSN, APN-BC, AOCN®, discusses tailored treatment selection, novel therapeutic strategies, treatment-related adverse events, and patient-centered care for patients with MM.

Optimizing Patient Outcomes in Pancreatic Cancer With Al B. Benson, MD, FACP, FASCO

0.25 CME | 0.25 MOC

The second episode of Oncology Data Advisor with Dr. Benson considers recent developments in genomic testings and targeted therapies, supportive care measures that can optimize quality of life, and strategies that can be utilized to improve outcomes of patients with pancreatic cancer.

New Thinking, New Strategies in Advanced Urothelial Carcinoma

0.75 CME | ILNA Points

This case-based presentation developed by Arjun V. Balar, MD, discusses patient and tumor-related factors that can inform personalized care plans as well as novel therapies and adverse event management. Click to learn more and start the activity!

Nursing Management of Myelofibrosis: Controlling Symptoms and Optimizing Patient Quality of Life

1.0 NCPD | ILNA Points

This online session features a discussion between Alice Lynn, ANP, and Dawn C. Urbanovsky, RN, BSN, OCN^®, on the clinical signs and symptoms of myelofibrosis, JAK inhibitor therapy, and optimizing quality of life for patients receiving treatment for myelofibrosis.

Optimizing the Clinical Outcomes of Patients With Immune Thrombocytopenia

1.0 CME | 1.0 NCPD | 1.0 MOC

In this multidisciplinary discussion, James B. Bussel, MD & Allison Miller Imahiyerobo, APN explore ITP pathogenesis, current and emerging therapies, and supportive care strategies that help ITP patients achieve their goals of therapy. Register/sign in to get started!

Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The Nurse's View

1.0 NCPD | ILNA Points

In this case-based nursing activity, Brenda Martone, MSN, ANP-BC, AOCNP^®, discusses tailored CRPC treatment plans, novel therapies, and adverse event management for metastatic and nonmetastatic CRPC. Start now!

Treatment Advances in Gastrointestinal Stromal Tumor With Shreyaskumar Patel, MD

0.25 CME | 0.25 NCPD | 0.25 MOC

This episode of Oncology Data Advisor features Dr. Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, in a discussion that covers the changing treatment landscape, adverse events of concern with novel therapies, and advice for members of the cancer care team as they seek to optimize outcomes for patients with GIST.

Nursing Management of Oral Mucositis

1.0 NCPD | ILNA Points

Oral mucositis is considered one of the most debilitating side effects of cancer therapy. This online activity reviews pathobiology, risk factors, clinical assessment, and supportive care interventions.

Nursing Management of Tumor Lysis Syndrome

1.0 NCPD | ILNA Points

TLS is an oncological emergency which can result in acute renal failure, cardiac arrhythmias, seizures, and even death. This online activity reviews signs and symptoms, risk factors, and supportive care interventions.

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

1.0 NCPD | ILNA Points

CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer

1.0 NCPD | ILNA Points

VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer

1.0 NCPD | ILNA Points

VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews VTE pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.

Management of Cancer Pain: Current Guidelines

1.0 NCPD | ILNA Points

Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.

Prevention of Medical Errors in Nursing Practice

1.0 NCPD | ILNA Points

Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting.

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

1.0 NCPD | ILNA Points

Studies have shown that certain cancer therapies adversely affect the heart and lead to various types of injuries, which often result in death. This activity reviews recent advances in the management of treatment-induced cardiotoxicity.

Nursing Management of Bone Health in Patients With Cancer

1.0 NCPD | ILNA Points

Once it has metastasized to the skeletal system, cancer often negatively affects bone health, leading to pain, fractures, hypercalcemia, and nerve compression. This online activity reviews interventions to reduce morbidity and mortality of bone complications in patients with cancer.

Free CME/NCPD Live Meetings

Understanding Evolving Treatment Paradigms in Advanced Hepatocellular Carcinoma

1.0 CME/NCPD | VA/DoD Meeting Series

This case-based activity will bring a leading clinical investigator to your VA/DoD medical center to discuss prognostic factors that can inform personalized care plans, novel therapies, and adverse event management. Schedule a meeting today!

Optimizing Therapeutic Strategies in Castration-Resistant Prostate Cancer

1.0 CME/NCPD/CPE | VA/DoD Meeting Series

This activity will discuss emerging efficacy and safety data on novel therapies for nmCRPC and mCRPC, strategies to manage adverse events, and the role of imaging studies and PSA testing in evaluating treatment response. Schedule a meeting today!

Keeping Pace With Evolving Treatment Paradigms in Advanced Renal Cell Carcinoma: The Nurse’s View

1.0 NCPD | ONS & SUNA Chapter Virtual Meeting Series

This virtual meeting series for ONS and SUNA chapters will distinguish mechanisms of action of IO agents and VEGFR TKI therapies for advanced RCC. Nurses will learn more about improving treatment tolerability, controlling adverse events, and ensuring provision of patient-centered RCC care. Book a meeting for your chapter!

Multiple Myeloma: Enhancing Treatment Tolerability, Adherence, and Patient-Centered Care

1.0 NCPD | ONS Chapter Meeting Series

This case-based nursing activity will come to your ONS chapter to discuss predictive and prognostic markers, treatment-related adverse events, patient-centered care, and novel therapeutic strategies for newly diagnosed and relapsed/refractory MM. Schedule a meeting today!

New Directions in the Management of Relapsed/Refractory Follicular Lymphoma

1.0 CME | Visiting Professor Lecture Series

This case-based visiting professor lecture series will bring a leading clinical investigator to your cancer center to discuss personalized care planning and novel therapeutic approaches for relapsed/refractory FL. Schedule a meeting today!

New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations

1.0 CME | Visiting Faculty Meeting Series

Are you developing personalized care plans for your patients with advanced NSCLC? This activity will bring a leading clinical expert to your institution to discuss the use of molecular biomarkers to refine selection of novel therapies. Enroll your institution today!

Enhancing Treatment Experiences in Castration-Resistant Prostate Cancer: The Nurse's View

1.0 NCPD | Visiting Faculty Meeting Series

This case-based nursing activity will bring a leading clinical investigator to your institution to discuss tailored CRPC treatment plans, novel therapies, and adverse event management for metastatic and nonmetastatic CRPC. Schedule a meeting today!

New Clinical Perspectives in the Management of Myelofibrosis

1.0 CME | Visiting Faculty Meeting Series

This live meeting series will bring a leading clinical investigator to your institution to discuss predictive and prognostic markers, personalized care plans, emerging data, and research advances in the management of myelofibrosis. Request a meeting today!

Defining Personalized Care Plans in Metastatic Colorectal Cancer

1.0 CME | Virtual Visiting Faculty Meeting Series

Book one of these virtual visiting faculty meetings for your institution! This case-based presentation will discuss tailored treatment, novel therapies, and optimizing treatment experiences for patients with metastatic colorectal cancer. Click to learn more!

Company

Resources

Follow Us

Copyright © 2020 i3 Health. All rights reserved.